ChemoMetec A/S (CHEMM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ChemoMetec A/S (CHEMM) has a cash flow conversion efficiency ratio of 0.139x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr90.64 Million ≈ $14.18 Million USD) by net assets (Dkr652.59 Million ≈ $102.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of ChemoMetec A/S to measure how much of total assets are equity-financed.
ChemoMetec A/S - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how ChemoMetec A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CHEMM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
ChemoMetec A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChemoMetec A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daou Tech
KO:023590
|
0.125x |
|
Actions Technology Co Ltd
SHG:688049
|
0.043x |
|
Hunan Huakai Cultural and Creative Co Ltd
SHE:300592
|
0.048x |
|
Wavestone S.A.
PA:WAVE
|
0.032x |
|
Yantai Changyu Pioneer Wine Co Ltd
SHE:000869
|
0.011x |
|
VERBIO Vereinigte BioEnergie AG
XETRA:VBK
|
-0.023x |
|
Compagnie des Alpes S.A.
PA:CDA
|
-0.029x |
|
JiangSu Jin Tong Ling Fluid Mach
SHE:300091
|
-0.044x |
Annual Cash Flow Conversion Efficiency for ChemoMetec A/S (2005–2025)
The table below shows the annual cash flow conversion efficiency of ChemoMetec A/S from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is ChemoMetec A/S worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | Dkr673.36 Million ≈ $105.35 Million |
Dkr207.45 Million ≈ $32.46 Million |
0.308x | +35.01% |
| 2024-06-30 | Dkr565.32 Million ≈ $88.45 Million |
Dkr129.00 Million ≈ $20.18 Million |
0.228x | -21.09% |
| 2023-06-30 | Dkr533.04 Million ≈ $83.40 Million |
Dkr154.15 Million ≈ $24.12 Million |
0.289x | -41.59% |
| 2022-06-30 | Dkr357.20 Million ≈ $55.89 Million |
Dkr176.86 Million ≈ $27.67 Million |
0.495x | +21.59% |
| 2021-06-30 | Dkr264.98 Million ≈ $41.46 Million |
Dkr107.90 Million ≈ $16.88 Million |
0.407x | +14.64% |
| 2020-06-30 | Dkr202.75 Million ≈ $31.72 Million |
Dkr72.02 Million ≈ $11.27 Million |
0.355x | +5.59% |
| 2019-06-30 | Dkr173.34 Million ≈ $27.12 Million |
Dkr58.31 Million ≈ $9.12 Million |
0.336x | -3.44% |
| 2018-06-30 | Dkr73.01 Million ≈ $11.42 Million |
Dkr25.44 Million ≈ $3.98 Million |
0.348x | +129.87% |
| 2017-06-30 | Dkr64.38 Million ≈ $10.07 Million |
Dkr9.76 Million ≈ $1.53 Million |
0.152x | -49.91% |
| 2016-06-30 | Dkr56.85 Million ≈ $8.89 Million |
Dkr17.20 Million ≈ $2.69 Million |
0.303x | +4.70% |
| 2015-06-30 | Dkr46.35 Million ≈ $7.25 Million |
Dkr13.39 Million ≈ $2.10 Million |
0.289x | +127.07% |
| 2014-06-30 | Dkr44.53 Million ≈ $6.97 Million |
Dkr5.67 Million ≈ $886.64K |
0.127x | -29.63% |
| 2013-06-30 | Dkr43.23 Million ≈ $6.76 Million |
Dkr7.82 Million ≈ $1.22 Million |
0.181x | -12.56% |
| 2012-06-30 | Dkr42.86 Million ≈ $6.71 Million |
Dkr8.87 Million ≈ $1.39 Million |
0.207x | +39.88% |
| 2011-06-30 | Dkr52.71 Million ≈ $8.25 Million |
Dkr7.79 Million ≈ $1.22 Million |
0.148x | +15.98% |
| 2010-06-30 | Dkr52.62 Million ≈ $8.23 Million |
Dkr6.71 Million ≈ $1.05 Million |
0.127x | -53.18% |
| 2009-06-30 | Dkr56.31 Million ≈ $8.81 Million |
Dkr15.33 Million ≈ $2.40 Million |
0.272x | +950.04% |
| 2008-06-30 | Dkr51.71 Million ≈ $8.09 Million |
Dkr1.34 Million ≈ $209.81K |
0.026x | +225.62% |
| 2007-06-30 | Dkr39.34 Million ≈ $6.15 Million |
Dkr-812.00K ≈ $-127.04K |
-0.021x | -170.06% |
| 2006-06-30 | Dkr16.50 Million ≈ $2.58 Million |
Dkr486.00K ≈ $76.04K |
0.029x | +18.05% |
| 2005-06-30 | Dkr-11.34 Million ≈ $-1.77 Million |
Dkr-283.00K ≈ $-44.28K |
0.025x | -- |
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more